Skip to main content
    O

    OS Therapies Incorporated (OSTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $0.68
    -0.06 (-8.66%)

    Market Cap: $34.87M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    OS Therapies Incorporated (OSTX) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to OS Therapies are Plus Therapeutics (PSTV), Gain Therapeutics (GANX) and Serina Therapeutics (SER). By market cap, OS Therapies ranks 9th of the 13 companies on this page; Oncolytics Biotech (ONCY) is the largest at $48.51M.

    Peer Comparison

    OSTX's ROIC of 218.0% is above the peer median of -140.0%, and its revenue growth of 0.0% is in line with the median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    OS Therapies (OSTX)$34.87MN/AN/A0.0%218.0%0.0%0.00%
    Plus Therapeutics Inc (PSTV)$26.64MN/A2.0x-230.2%-827.8%-2.9%0.00%
    Gain Therapeutics Inc (GANX)$46.31MN/AN/A0.0%-170.5%-100.0%0.00%
    Serina Therapeutics Inc (SER)$36.93MN/A288.7x0.0%-109.4%154.9%0.00%
    Oncolytics Biotech Inc (ONCY)$48.51MN/AN/A0.0%N/A0.0%0.00%
    ProMIS Neurosciences Inc. (PMN)$29.60MN/AN/A0.0%N/A0.0%0.00%
    Lite Strategy, Inc. (LITS)$25.30MN/AN/A0.0%N/A0.0%0.00%
    Grace Therapeutics, Inc. (GRCE)$38.08MN/AN/A0.0%N/A0.0%0.00%
    Pelthos Therapeutics Inc. (PTHS)$29.24MN/A0.5x-199.5%-95.4%0.0%0.00%
    Rein Therapeutics Inc (RNTX)$47.63MN/AN/A0.0%N/A0.0%0.00%
    Telomir Pharmaceuticals, Inc. Common Stock (TELO)$36.15MN/AN/A0.0%N/A0.0%0.00%
    Mural Oncology plc (MURA)$35.38MN/AN/A0.0%-173.6%0.0%0.00%
    Elicio Therapeutics Inc. (ELTX)$42.46MN/AN/A0.0%-96.6%0.0%0.00%
    Peer median$36.54MN/A2.0x0.0%-140.0%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to OS Therapies, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Plus Therapeutics Inc (PSTV)
    Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing...
    PSTV competitors
    Gain Therapeutics Inc (GANX)
    Gain Therapeutics, Inc., a developing biotechnology company, is dedicated to developing a variety of therapies to treat diseases caused by protein misfolding.
    GANX competitors
    Serina Therapeutics Inc (SER)
    Serina Therapeutics Inc is a pioneering biotechnology company focused on developing innovative solutions for unmet medical needs in oncology and neurology...
    SER competitors
    Oncolytics Biotech Inc (ONCY)
    Oncolytics Biotech Inc., a developing-stage biopharmaceutical company, focuses on the discovery and development of pharmaceuticals for the treatment of cancer.
    ONCY competitors
    ProMIS Neurosciences Inc. (PMN)
    ProMIS Neurosciences Inc. is a pioneering biotechnology company focused on the development of innovative therapeutic solutions for neurodegenerative diseases...
    PMN competitors
    Lite Strategy, Inc. (LITS)
    Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer.
    LITS competitors
    Grace Therapeutics, Inc. (GRCE)
    Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.
    GRCE competitors
    Pelthos Therapeutics Inc. (PTHS)
    Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens.
    PTHS competitors
    Rein Therapeutics Inc (RNTX)
    Rein Therapeutics Inc (RNTX) is a forward-thinking biopharmaceutical company dedicated to developing innovative therapies for neurodegenerative disorders...
    RNTX competitors
    Telomir Pharmaceuticals, Inc. Common Stock (TELO)
    Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human...
    TELO competitors
    Mural Oncology plc (MURA)
    Mural Oncology plc is a pioneering biotechnology company dedicated to developing targeted therapies for solid tumors...
    Elicio Therapeutics Inc. (ELTX)
    Elicio Therapeutics Inc. (ELTX) is a clinical-stage biotechnology company specializing in innovative immunotherapies for cancer treatment.
    ELTX competitors

    Frequently Asked Questions About OSTX

    Who are OS Therapies' main competitors?

    The companies most similar to OS Therapies include Plus Therapeutics (PSTV), Gain Therapeutics (GANX), Serina Therapeutics (SER), Oncolytics Biotech (ONCY) and ProMIS Neurosciences (PMN), listed from the closest match.

    Who is OS Therapies' biggest competitor?

    Oncolytics Biotech (ONCY) is the largest of the similar companies at $48.51M; Plus Therapeutics (PSTV) is the closest match by business profile, size, sector and industry.

    How does OSTX stock compare with its competitors?

    OSTX's net margin is 0.0% against a peer median of 0.0%.

    Which of OS Therapies' competitors pays a higher dividend?

    OS Therapies pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is OS Therapies bigger than its competitors?

    No. OS Therapies is 9th by market cap among the 13 companies on this page; the largest is Oncolytics Biotech (ONCY) at $48.51M.